The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.
第一作者:
M O,Leach
第一单位:
Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK. martin.leach@icr.ac.uk
作者:
主题词
血管生成抑制剂(Angiogenesis Inhibitors);抗肿瘤药(Antineoplastic Agents);临床试验(主题)(Clinical Trials as Topic);评价研究(主题)(Evaluation Studies as Topic);磁共振成像(Magnetic Resonance Imaging);肿瘤(Neoplasms);结果可重复性(Reproducibility of Results);科学术语(主题)(Terminology as Topic)
DOI
10.1038/sj.bjc.6602550
PMID
15870830
发布时间
2022-03-30
- 浏览127

British journal of cancer
1599-610页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文